AKTUALNOŚCI
WCCI Warsaw, czyli jak będzie wyglądała przyszłość leczenia pacjentów kardiologicznych w Polsce w najbliższych latach?
Już w kwietniu Warszawa stanie się kardiologiczną stolicą Europy. W dniach 5–7 kwietnia 2017 roku na XXI edycji Warsztatów Kardiologii Interwencyjnej – Warsaw Course on Cadiovascular Interventions (WCCI) spotkają się najlepsi specjaliści z całego świata, by wymieniać się doświadczeniami w kardiologii i kardiochirurgii.
WCCI jest oficjalną konferencją Asocjacji Interwencji Sercowo-Naczyniowych Polskiego Towarzystwa Kardiologicznego (AISN PTK) i jest przez nią akredytowana. Multimedialne prezentacje, symultaniczne konferencje oraz interaktywne warsztaty praktyczne, organizowane przez Fundację Wspierania Kardiologii Interwencyjnej odbywają się pod patronatem Kliniki Kardiologii Inwazyjnej CSK MSWiA oraz Kliniki Kardiologii i Angiologii Interwencyjnej Instytutu Kardiologii w Warszawie. WCCI jest jednym z trzech najważniejszych i największych międzynarodowych kongresów kardiologicznych w naszym kraju.
Tematyka warsztatów koncentruje się głównie na problematyce związanej z rozpoznawaniem i leczeniem ostrych zespołów wieńcowych, stabilną chorobą wieńcową, wadami strukturalnymi i zastawkowymi serca oraz interwencjami w miażdżycy tętnic obwodowych.
Szczegóły znajdują się na stronie: http://wcci.pl/
Serdecznie zapraszamy
Prof. dr hab. n. med. Adam Witkowski
Prof. dr hab. n. med. Robert J. Gil
21st Warsaw Course on Cardiovascular Interventions
Wednesday, 5th April, 2017
09:00–09:50 Press Conference
09:00–16:00 MASTER CLASS @ WCCI 2017. A patient with NSTE-ACS and mutivessel coronary artery disease
10:00–11:55 Opieka kompleksowa w kardiologii – dokąd zmierzamy? Cykl debat z uczestnictwem przedstawicieli Ministerstwa Zdrowia, Narodowego Funduszu Zdrowia, AOTMiT, pracodawców i ekspertów klinicznych
10:00–10:55 Pacjent po zawale serca – jak funkcjonuje modelowe rozwiązanie dla opieki kompleksowej w kardiologii w praktyce?
11:00–11:55 Wyzwania dla ochrony zdrowia w Polsce: Jak wygląda wprowadzanie nowych leków i technologii medycznych do praktyki klinicznej?
11:55–12:05 Coffe Break
12:05–13:05 Special Session of the Association on Cardiovascular Interventions of the Polish Cardiac Society: Focuse on acute stroke treatment in Poland (Session in Polish)
12:05–12:15 Epidemiologia, patofizjologia oraz kliniczna prezentacja ostrego niedokrwiennego udaru mózgu. Leczenie interwencyjne: tromboliza i trombektomia
12:15–12:27 Leczenie trombolityczne – wciąż leczenie z wyboru w ostrym niedokrwiennym udarze mózgu?
12:27–12:39 Polskie doświadczenia leczenia ostrego udaru mózgu za pomocą trombektomii mechanicznej
12:39–12:50 Leczenie interwencyjne ostrego niedokrwiennego udaru mózgu – jak powinno przebiegać wdrożenie progamu w szpitalu?
12:50–13:05 Dyskusja (Discussion)
13:05–13:15 Coffe Break
13:15–14:45 LUNCH (lunch boxes at satellite symposia)
13:15–14:45 Room A. Satellite Lunch Symposium 1
13:15–14:45 Room B. Satellite Lunch Symposium 2
13:15–14:45 Room C. Satellite Lunch Symposium 3
13:15–14:45 Room Hemisphere (level -1). Satellite Lunch Symposium 4.
14:45–15:00 Coffe Break
15:00–17:05 European CTO Club session: How to build the program of CTO recanalization at my centre? Advices from the Best
15:00–15:40 Live case 1. CTO PCI
15:40–15:50 The staff – training & experience
15:50–16:00 The stuff – equipment & radiation safety
16:00–16:10 Basic and advanced devices for chronic total occlusions
16:10–16:20 Case selection and indications
16:20–17:00 CTO PCI presented as the recorded case with discussion
17:00–17:05 Take home message
17:05–17:20 Coffee Break
17:20–20:00 Room A+B. European Bifurcation Club session: Practical approach for choosing the optimal strategy for intervention with coronary bifurcation lesions
17:20–18:00 Life case 3. Patient with distal left main stenosis (PTS approach)
18:00–18:12 Provisional stenting as a default strategy
18:12–18:55 Live case 4. Patients with true bifurcation lesion (two stents approach)
18:55–19:07 Complex strategy for bifurcation. Why and what is the best technique?
19:07–19:19 Optimization measures and practical algorithm
19:19–20:00 Live case 5. Bifurcation PCI
15:00–16:20 Room C. Symposium: Innovations in technology – what is new for the interventionalists?
15:00–15:05 Introduction and objectives. Presentations of Industry Innovations
16:22–16:27 Take-home message
16:00–20:00 Room Hemisphere. Session for nurses and technicians (Session in Polish)
16:30–18:01 Room C. Central and Eastern European Session – Progress in the interventional cardiology
Presentations by countries
17:54–18:01 Discussion and Wrap up
20:00–21:30 BOARDROOM. Meeting of the Board of the Association on Cardiovascular Interventions of the Polish Cardiac Society
AIDA ROOM: Training Room Medtronic
Thursday, April 6th, 2017
7:00–8.00 BOARDROOM. Meeting of the Editorial Board of the Invasive Cardiology Journal
8:00–9:30 ROOM RUBINSTEIN (second floor). General Assembly of the Association on Cardiovascular Interventions of the Polish Cardiac Society
9:30–11:00 Room C. Session 1. Acute Coronary Syndrome Session: lectures, live cases, case-based presentations
9:30–10:00 Live case 1. Patient with NSTE-ACS and multivessel CAD
Symposium: Acute coronary syndrome – not only primary angioplasty
10:30–10:40 MINOCA – pathogenesis, treatment & prognosis
10:40–10.50 Myocardial infarction type 2 – how to treat?
10:50–11:00 Cardiac surgery in acute coronary syndromes – when & how?
11:00–11:30 Live case 2. Patient with NSTE-ACS and left main stenosis
11:30–11:45 Featured Lecture. NSTE-ACS: How to tailor antithrombotic and antiplatelet therpay to improve safety and efficacy of percutaneous treatment?
11:45–12:30 Room C. Session 2. Acute coronary syndrome: case review session
11:45–12:00 Case 1
12:00–12:03 Discussion
12:03–12:18 Case 2
12:18–12:21 Discussion
12:40–13:10 Room C. Opening Ceremony
1. Robert J. Gil and Adam Witkowski, WCCI Directors
2. Piotr Hoffman, President of the Polish Cardiac Society
3. Jacek Legutko, Chairman of Association on Cardiovascular Interventions of the Polish Cardiac Society
4. Andreas Baumbach, President-Elect of the EAPCI
5. William Wijns, Chairman of PCR
6. Andreas Award
13:10–13:20 Coffe break
13:20–17:50 PCR Learning Pathway on Left Main Angioplasty
13:20–16:55 Room A+B. Learning PCI in Left Main Coronary Disease
PCR SESSION @ WCCI
13:20–14:20 Live-in-a box cases 1 and 2
14:20–15:20 Lunch
14:30–15:00 Boardroom. Editorial Board Meeting of the Advances in the Interventional Cardiology
PCR SESSION @ WCCI
15:20–16:00 Room A+B. How Should I treat Left Main Disease? Part 1
15:20–15:25 Introduction and objectives
Case 1.
Speaker 1: Case presentation (5 minutes)
Expert 1: How would I treat? (7 minutes)
Expert 2: How would I treat? (7 minutes)
Speaker 1 (5 minutes)
Discussion (10 minutes)
Consensus (5 minutes)
16:00–16:10 Coffe break
PCR SESSION @ WCCI
16:10–17:50 Room A+B. How Should I treat Left Main Disease? Part 2.
16:10–16:15 Introduction and objectives
Case 2.
Speaker 2: Case presentation (5 minutes)
Expert 1: How would I treat? (7 minutes)
Expert 2: How would I treat? (7 minutes)
Speaker 2: How did I treat. (5 minutes)
Discussion (10 minutes)
Consensus (5 minutes)
13:20–16:30 Room C. Coronary Symposium, part 1. Frequent PCI complications. How to deal with…
13:20–13:28 How to deal with occlusive coronary dissection?
13:28–13:36 How to deal with coronary perforation?
13:36–13:44 How to deal with calcified lesion?
13:44–13:52 How to deal with lost stent?
13:52–13:57 Wrap-up
13:57–14:35 Live case 3. PCI in MVD CAD with ROTA
14:35–15:12 Room C. Coronary Symposium, part 2. How to deal with thrombotic complications?
14:35–14:43 In-stent thrombosis
14:43–14:51 No-reflow in myocardial infarction and during elective procedure
14:51–14:59 Stroke in pts undergoing PCI
14:59–15:07 Pulmonary embolism in pts undergoing PCI
15:07–15:12 Wrap-up
15:12–16:42 Room C. Forum on transcather aortic valve implantation: case review
15:12–15:17 Learning objectives
15:17–15:27 Case 1
15:27–15:32 Discussion
15:32–15:42 Case 2
15:42–15:47 Discussion
15:47–15:57 Case 3
15:57–16:02 Discussion
16:02–16:12 Case 4
16:12–16:17 Discussion
16:17–16:27 Case 5
16:27–16:32 Discussion
16:32–16:42 Take-home message
16:42–17:58 Room C. Session 4: Fractional flow reserve – when, whom and how?
16:42–16:54 FFR: Basics indications and use in stable coronary cases
16:54–17:06 FFR and/or iFR in MVD assessment
17:06–17:18 Multivessel FFR assessment in acute coronary syndromes
17:18–17:58 Live case 5. PCI in MV CAD with iFR and FFR
18.06–19.20 Room A+B. Live case broadcasts of our friendly centres
18:06–18:46 Live case 6. A patient with multivessel coronary artery disease. Hungarian experience from Budapest
18:46–19:26 Live case 7. A patient with multivessel coronary artery disease. Czech experience from Brno
19:26–19:30 Wrap-up
17:58–19:23 Room C. Session 3. Left main disease – how to solve the problems optimally?
17:58–18:13 Left main stenting – my favourite technique is provisional one but I like dedicated bifurcation stents very much…
18:13–18:28 Two stents technique – overview and expert recommendation
18:28–18:43 Intravascular imaging for bifurcation stenting: IVUS or OCT is better
18:43–19:23 Live case 4. PCI in LMCA with IVUS/OCT
AIDA ROOM: Training Room Medtronic
Friday, 7th April, 2017
7:30–9:00 BOARDROOM. Meeting of the POLBOS 3 Study Investigators
Room A
9:00–11:15 Session 1. Selected Complex structural interventions from A to Z
9:00–9:05 Learning objectives
9:05–9:45 Life case 1. LAAC
9:45–10:00 Coarctation of aorta stenting in adults
10:00–10:15 PFO closure
10:15–10:30 Left atrial appendix closure in patient with AF
10:30–10:45 Coronary fistulas closure
10:45–11:00 Novel 3-D image fusionsoftware for guidance of complex catheterization in congenital heart diseases
11:00–11:10 Discussion
11:10–11:15 Take-home message
11:15–11:30 Coffee Break
Room B
9:00–11:15 Session 2. Peripheral arteries revascularization
9:00–9:05 Learning objectives
9:05–9:17 Strategy of treatment in patients with concomitant atherosclerosis of coronary and carotid arteries
9:17–9:29 Transcatheter management of acute stroke
9:30–10:10 LIVE IN A BOX 1: (carotid or renal)
10:10–10:22 Overview of Subclavian and Innominate Artery Interventions
10:22–10:34 Renal Denervation. Current Status and Future Directions
10:34–10:46 How to treat patients with critical limb ischemia? Endovascular therapy vs surgical bypass
10:46–11:05 Discussion
11:05–11:15 Take-home message
11:15–11:30 Coffee Break
Room C
9:00–10:10 session 3. Symposium: 2017`s update. What interventionist should know…
Session 1. Reality vs needs in intracoronary imaging
9:00–9:10 The reimbursement of intracoronary imaging in Poland – status quo and clinical examples
9:10–9:20 Left main PCI – a real indication for intravascular ultrasound
9:20–9:30 Early and late stent failure in OCT
9:30–9:40 Post transplant vascular allograft – for whom, how and when?
9:40–10:10 Live case 2. Left Main PCI
FEATURED LECTURE
10:10–10:25 Left main stenting: landscape after NOBLE and EXCEL Trials. Is any need for further trials?
Room C
10:25–11:35 Session 4. Coronary bioresorbable scaffolds – from concept to clinical outcomes
10:25–10:37 Technical aspects of BVS implantation
10:37–10:49 Clinical outcomes of BRS – in search of excellence
10:50–11:30 Live case 3. PCI with bioresorbable stents
11:30–11:35 Take-home message
11:10–11:30 Coffee Break
Room A
11:30–13:00 Complications Session. My most complicated case
11:30–11:35 Session objectives
11:35–11:40 Case 1
11:40–11:43 Discussion
11:43–11:48 Case 2
11:48–11:51 Discussion
11:51–11:56 Case 3
11:56–11:59 Discussion
11:59–12:04 Case 4
12:04–12:07 Discussion
12:07–12:12 Case 5
12:12–12:15 Discussion
12:15–12:20 Case 6. TBD
12:20–12:23 Discussion
12:23–12:28 Case 7
12:28–12:31 Discussion
12:31–12:36 Case 8
12:36–12:39 Discussion
12:39–12:44 Take home message
12:45–13:25 Live case 4. PCI of calcified lesions
13:25–13:40 Featured lecture. Magnetocardiography II: Differential diagnosis of coronary artery disease vs myocardial microangiopathy vs vulnerable coronary plaques
Room B
11:30–13:05 Session 4. TAVI
11:30–11:35 Session objectives
11:35–12:20 Live case 5: TAVI (valve to be decided)
12:20–12:32 Who is a good candidate for TAVI – today’s practice
12:32–12:44 Intermediate and low risk patients – ready for prime time in 2017?
12:44–12:56 Brain protection during TAVI – are data in to use it in all patients?
12:56–13:08 Alternative approaches to TAVI
13:08–13:20 Long-term follow-up after TAVI: a word of concern?
13:20–13:25 Take-home message
Room C
11:30–15:00 Session 5. Interventional options for mitral regurgitation
11:30–11:40 Session objectives
11:40–11:55 Interventional treatment of functional mitral regurgitation – surgical point of view
11:55–12:10 Interventional treatment of functional mitral regurgitation – cardiologist’s point of view
12:10–12:25 Degenerative mitral regurgitation – is there a place for the transcatheter therapy?
12:25–12:40 Where is the limit? Borderline and chalanging mitral valve anatomy for the MitraClip device
12:40–13:55 Treatment of degenerative mitral regurgitation with an expanded polytetrafluoroethylene cordal implantation device. Initial clinical experience
13:55–14:10 The central role of echocardiographic guidance for patient’s selection and procedure monitoring during MitraClip and Harpoon TSD-5 implantation
14:10–14:50 LIVE IN A BOX 2. MitraClip in a patient with functional mitral regurgitation
14:50–15:00 Take-home mesage
AIDA ROOM: Training Room Medtronic